mannitol has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Florova, G; Hengsawas Surasarang, S; Idell, S; Komissarov, AA; Shetty, S; Williams, RO | 1 |
| Alaienia, C; Kanth, PM; Smaldone, GC | 1 |
2 other study(ies) available for mannitol and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Formulation for a novel inhaled peptide therapeutic for idiopathic pulmonary fibrosis.
Topics: Administration, Inhalation; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Liberation; Drug Stability; Freeze Drying; Humidity; Idiopathic Pulmonary Fibrosis; Lactose; Mannitol; Trifluoroacetic Acid | 2018 |
Nebulized Mannitol, Particle Distribution, and Cough in Idiopathic Pulmonary Fibrosis.
Topics: Administration, Inhalation; Aged; Bronchial Spasm; Cough; Drug Carriers; Female; Forced Expiratory Volume; Humans; Idiopathic Pulmonary Fibrosis; Interferons; Male; Mannitol; Middle Aged; Nebulizers and Vaporizers; Particle Size; Vital Capacity | 2018 |